Impact of using two dialyzers in parallel on phosphate clearance in hemodialysis patients: a randomized trial.

about

Impact of using two dialyzers in parallel on phosphate clearance in hemodialysis patients: a randomized trial.

Item

http://www.wikidata.org/entity/Q38865935

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Impact of using two dialyzers ...... patients: a randomized trial.

@en

type

Item

label

Impact of using two dialyzers ...... patients: a randomized trial.

@en

prefLabel

Impact of using two dialyzers ...... patients: a randomized trial.

@en

P1476

Impact of using two dialyzers ...... patients: a randomized trial.

@en

P2093

Anita Lloyd

http://www.w3.org/2001/XMLSchema#string

Braden Manns

http://www.w3.org/2001/XMLSchema#string

Brenda Hemmelgarn

http://www.w3.org/2001/XMLSchema#string

Larry Unsworth

http://www.w3.org/2001/XMLSchema#string

Mark Courtney

http://www.w3.org/2001/XMLSchema#string

Scott Klarenbach

http://www.w3.org/2001/XMLSchema#string

Stephanie Thompson

http://www.w3.org/2001/XMLSchema#string

P2860

Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management.

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study.

Prescribed dietary phosphate restriction and survival among hemodialysis patients.

FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis.

Kinetic model of phosphorus mobilization during and after short and conventional hemodialysis

Kinetics of beta2-microglobulin and phosphate during hemodialysis: effects of treatment frequency and duration.

Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients

Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials.

Biomarkers of vascular calcification and mortality in patients with ESRD.

Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis.

P304

855-861

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NDT/GFW085

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Marcello Tonelli

Jennifer M MacRae

P577

2016-04-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27190374

http://www.w3.org/2001/XMLSchema#string